252 related articles for article (PubMed ID: 23824562)
1. Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment.
Wang T; Kumru OS; Yi L; Wang YJ; Zhang J; Kim JH; Joshi SB; Middaugh CR; Volkin DB
J Pharm Sci; 2013 Aug; 102(8):2520-37. PubMed ID: 23824562
[TBL] [Abstract][Full Text] [Related]
2. The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody.
Wakankar AA; Liu J; Vandervelde D; Wang YJ; Shire SJ; Borchardt RT
J Pharm Sci; 2007 Jul; 96(7):1708-18. PubMed ID: 17238195
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.
Kirley TL; Norman AB
Hum Vaccin Immunother; 2015; 11(2):458-67. PubMed ID: 25692880
[TBL] [Abstract][Full Text] [Related]
4. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
[TBL] [Abstract][Full Text] [Related]
5. Effect of polyethylene glycol conjugation on conformational and colloidal stability of a monoclonal antibody antigen-binding fragment (Fab').
Roque C; Sheung A; Rahman N; Ausar SF
Mol Pharm; 2015 Feb; 12(2):562-75. PubMed ID: 25548945
[TBL] [Abstract][Full Text] [Related]
6. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.
Kim N; Remmele RL; Liu D; Razinkov VI; Fernandez EJ; Roberts CJ
Biophys Chem; 2013 Feb; 172():26-36. PubMed ID: 23334430
[TBL] [Abstract][Full Text] [Related]
7. Isomerization of Asp-Asp motif in model peptides and a monoclonal antibody Fab fragment.
Yi L; Beckley N; Gikanga B; Zhang J; Wang YJ; Chih HW; Sharma VK
J Pharm Sci; 2013 Mar; 102(3):947-59. PubMed ID: 23280575
[TBL] [Abstract][Full Text] [Related]
8. Effects of ionic strength and sugars on the aggregation propensity of monoclonal antibodies: influence of colloidal and conformational stabilities.
Saito S; Hasegawa J; Kobayashi N; Tomitsuka T; Uchiyama S; Fukui K
Pharm Res; 2013 May; 30(5):1263-80. PubMed ID: 23319172
[TBL] [Abstract][Full Text] [Related]
9. Stability of monoclonal antibodies at high-concentration: head-to-head comparison of the IgG1 and IgG4 subclass.
Neergaard MS; Nielsen AD; Parshad H; Van De Weert M
J Pharm Sci; 2014 Jan; 103(1):115-27. PubMed ID: 24282022
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives.
Wu G; Wang S; Tian Z; Zhang N; Sheng H; Dai W; Qian F
Eur J Pharm Biopharm; 2017 Nov; 120():1-8. PubMed ID: 28754261
[TBL] [Abstract][Full Text] [Related]
11. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
[TBL] [Abstract][Full Text] [Related]
12. Reversible NaCl-induced aggregation of a monoclonal antibody at low pH: Characterization of aggregates and factors affecting aggregation.
Bickel F; Herold EM; Signes A; Romeijn S; Jiskoot W; Kiefer H
Eur J Pharm Biopharm; 2016 Oct; 107():310-20. PubMed ID: 27449627
[TBL] [Abstract][Full Text] [Related]
13. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
[TBL] [Abstract][Full Text] [Related]
14. Distinct aggregation mechanisms of monoclonal antibody under thermal and freeze-thaw stresses revealed by hydrogen exchange.
Zhang A; Singh SK; Shirts MR; Kumar S; Fernandez EJ
Pharm Res; 2012 Jan; 29(1):236-50. PubMed ID: 21805212
[TBL] [Abstract][Full Text] [Related]
15. Characterization of deamidation at Asn138 in L-chain of recombinant humanized Fab expressed from Pichia pastoris.
Ohkuri T; Murase E; Sun SL; Sugitani J; Ueda T
J Biochem; 2013 Oct; 154(4):333-40. PubMed ID: 23853311
[TBL] [Abstract][Full Text] [Related]
16. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
[TBL] [Abstract][Full Text] [Related]
17. The effect of arginine glutamate on the stability of monoclonal antibodies in solution.
Kheddo P; Tracka M; Armer J; Dearman RJ; Uddin S; van der Walle CF; Golovanov AP
Int J Pharm; 2014 Oct; 473(1-2):126-33. PubMed ID: 24992318
[TBL] [Abstract][Full Text] [Related]
18. Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.
Cheng W; Joshi SB; He F; Brems DN; He B; Kerwin BA; Volkin DB; Middaugh CR
J Pharm Sci; 2012 May; 101(5):1701-20. PubMed ID: 22323186
[TBL] [Abstract][Full Text] [Related]
19. Fc domain mediated self-association of an IgG1 monoclonal antibody under a low ionic strength condition.
Nishi H; Miyajima M; Wakiyama N; Kubota K; Hasegawa J; Uchiyama S; Fukui K
J Biosci Bioeng; 2011 Oct; 112(4):326-32. PubMed ID: 21783411
[TBL] [Abstract][Full Text] [Related]
20. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.
Thakkar SV; Joshi SB; Jones ME; Sathish HA; Bishop SM; Volkin DB; Middaugh CR
J Pharm Sci; 2012 Sep; 101(9):3062-77. PubMed ID: 22581714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
